MedPath

Magnetic Resonance Imaging of the Coronary Vessel Wall

Completed
Conditions
Coronary Artery Disease
Registration Number
NCT00456950
Lead Sponsor
Maastricht University Medical Center
Brief Summary

Despite advances in prevention and treatment, clinical manifestations of atherosclerosis (e.g. myocardial infarction, stroke) remain the largest cause of mortality in the Western world. The occurrence of acute ischemic syndromes, including unstable angina and myocardial infarction, is highly associated with atherosclerotic plaque morphology.

Magnetic resonance (MR) imaging is able to noninvasively depict the lumen of coronary arteries without the need for ionizing radiation. In addition, MR imaging is able to generate soft-tissue contrast unlike any other imaging modality. It has been shown in the aorta and carotid artery that MR imaging is able to identify different atherosclerotic plaque components in vivo. Similar MR imaging techniques are becoming available to visualize the coronary arterial wall and preliminary studies have shown the feasibility of MR coronary vessel wall imaging in humans.

The overall aim of the current study is to identify in vivo MR coronary vessel wall and plaque features that are associated with acute coronary syndromes. This study is divided into 2 substudies:

1. Detection of atherosclerosis in the coronary vessel wall with contrast-enhanced MR imaging in patients with coronary artery disease and age-matched healthy volunteers.

2. Characterization of coronary vessel wall plaque morphology in patients with stable and unstable angina: validation of MRI with the current standard of reference intravascular ultrasound (IVUS).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
75
Inclusion Criteria
  • patients with (un)stable angina or non-ST-elevated myocardial infarction
  • patients are scheduled for, or recently had X-ray coronary angiography
  • healthy volunteers, no clinical history of coronary artery disease(control group for substudy 1)
  • patients with non-ischemic heart disease, scheduled for X-ray coronary angiography (control group for substudy 2)
  • informed consent
Exclusion Criteria
  • severe arrhythmia
  • hemodynamic unstable patients
  • contra-indications for MRI

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Maastricht University Hospital

🇳🇱

Maastricht, Netherlands

Maastricht University Hospital
🇳🇱Maastricht, Netherlands

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.